TOLREMO therapeutics AG
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.tolremo.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid TumorAdult Solid TumorAdult DiseaseCancerNSCLC
- Interventions
- First Posted Date
- 2024-05-07
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- TOLREMO therapeutics AG
- Target Recruit Count
- 50
- Registration Number
- NCT06403436
- Locations
- 🇪🇸
NEXT Oncology Barcelona, Barcelona, Spain
🇪🇸Vall d'Hebron Institute of Oncology, Barcelona, Spain
🇪🇸NEXT Oncology Madrid, Madrid, Spain
News
No news found